Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Plus Omeprazole vs Fluticasone Alone for EoE
NCT03781596Phase 4Unknown
- Start
- Oct 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing Fluticasone and omeprazole with Fluticasone and placebo (2 arms). Primary endpoint: Change in esophageal eosinophilia at 8 weeks. Status: unknown.
02
Drugs
omeprazole
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT03781596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781596.